These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8139174)

  • 21. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.
    Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B
    Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P
    J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [LDL cholesterol apheresis by adsorption to dextran sulfate].
    Grunewald RW; Ditschuneit HH; Klein J; König W; Grunewald JM; Franz HE
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):194-6. PubMed ID: 1422078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporal low-density lipoprotein elimination by immunoadsorption.
    Ritter MM; Parhofer KG
    Ther Apher Dial; 2003 Jun; 7(3):370-2. PubMed ID: 12924615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmapheresis in familial hypercholesterolemia.
    Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
    Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL-Apheresis removes serum amyloid P and A in hypercholesterolemic patients.
    Palumbo B; Cardinali L; Sinzinger H
    Thromb Res; 2000 Mar; 97(6):491-4. PubMed ID: 10704659
    [No Abstract]   [Full Text] [Related]  

  • 28. 26 years of LDL--apheresis: a review of experience.
    Borberg H
    Transfus Apher Sci; 2009 Aug; 41(1):49-59. PubMed ID: 19559652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [LDL-apheresis--clinical indication and utility].
    Nakamura T; Ishikawa K
    Nihon Rinsho; 1999 Dec; 57(12):2854-61. PubMed ID: 10638225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The plasmoimmunosorption of low-density lipoproteins in the treatment of patients with hereditary hypercholesterolemia].
    Konovalov GA; Pokrovskiĭ SN; Trakht IN; Bokchubaev E; Volkova EI; Kukharchuk VV
    Ter Arkh; 1991; 63(7):65-70. PubMed ID: 1788813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-compartment model of cholesterol kinetics for establishment of treatment strategy of LDL apheresis in nephrotic hypercholesterolemia.
    Yashiro M; Muso E; Matsushima M; Nagura R; Sawanishi K; Sasayama S
    Blood Purif; 1994; 12(6):317-26. PubMed ID: 7865190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles.
    Hovland A; Marcovina S; Hardersen R; Enebakk T; Mollnes TE; Lappegård KT
    Transfus Apher Sci; 2012 Feb; 46(1):73-6. PubMed ID: 22206792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns.
    Gandjini H; Gambert P; Athias A; Mousson C; Rifle G; Lallemant C
    Transfus Sci; 1994 Sep; 15(3):289-97. PubMed ID: 10155547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.
    Gülle S; Bak M; Serdaroglu E; Can D; Karabay O
    Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P
    Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Apheresis of low-density lipids in the treatment of hereditary hypercholesterolemia].
    Konovalov GA; Kukharchuk VV; Sinitsin VV; Trakht IN; Adamova IIu
    Vutr Boles; 1989; 28(4):133-6. PubMed ID: 2596087
    [No Abstract]   [Full Text] [Related]  

  • 38. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
    Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
    Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Klinkmann J; Latza R
    J Clin Apher; 1996; 11(2):78-80. PubMed ID: 8844436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
    Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.